Key result
Having 10 or more genomic imbalances in pediatric adrenocortical cancer was associated with high mortality, whereas all patients with fewer than 10 imbalances remained in remission.
Why the study?
Does the number of genomic imbalances correlate with overall survival in children with adrenocortical cancer?
Observational (n=14)
Does the number of genomic imbalances correlate with overall survival in children with adrenocortical cancer?
Answers are grounded in this paper and cite their sources.
The number of genomic imbalances detected by comparative genomic hybridisation appears to have predictive value for overall survival in pediatric adrenocortical cancer.
BACKGROUND: Adrenocortical tumours (ACT) in children are rare and, if malignant, often associated with poor prognosis. Relevant cytogenetic factors for prognosis are hardly available. PROCEDURES: We analysed 14 adrenocortical cancers (ACC) of children by comparative genomic hybridisation (CGH). RESULTS: The total number of genomic imbalances ranged from 1 to 17 in individual tumour samples. The most common imbalances were +1q (57%), +12p (50%), +12q (50%), +1p (43%), +7q (42%), +9q (42%), +15q (42%), and -4q (57%), -11q (57%), -4p (42%), and -16q (42%). The median number of genomic changes was 5.5 (n = 8) in pT1-pT2 and 15.5 (n = 6) in pT3-pT4 tumours. The median number was 4 in the eight patients, who remain in remission more than 51 months and 15.5 in the six patients, who have died from the disease within 44 months. Moreover, all seven patients with less than 10 individual imbalances were in remission (median follow-up 72 months), while all but one patient with 10 and more individual imbalances (n = 7) have died from the disease (median survival time 30 months). Comparison of the data from children and adults revealed characteristic differences. Gain of 1p and loss of 4p, 4q and 16q are frequent in childhood and rare in adults. Inversely, loss of 1p is rare in childhood but frequent in adult ACT. CONCLUSION: The number of CGH imbalances appeared to have a predictive value for overall survival in paediatric ACC.
No takes yet. Share an insight, caveat, or question.
Loncarevic et al. (2008) conducted an observational in Adrenocortical cancer in childhood (n=14). ≥10 genomic imbalances vs. <10 genomic imbalances was evaluated on Death from disease. Having 10 or more genomic imbalances in pediatric adrenocortical cancer was associated with high mortality, whereas all patients with fewer than 10 imbalances remained in remission.
Synapse has enriched 10 related papers. Consider them for comparative context: